IRIS publication 279268961
Activation of liver X receptor suppresses the production of the IL-12 family of cytokines by blocking nuclear translocation of NF-kappa Bp50
RIS format for Endnote and similar
TY - JOUR - Canavan, M,McCarthy, C,Ben Larbi, N,Dowling, JK,Collins, L,O'Sullivan, F,Hurley, G,Murphy, C,Quinlan, A,Moloney, G,Darby, T,MacSharry, J,Kagechika, H,Moynagh, P,Melgar, S,Loscher, CE - 2014 - October - Innate Immunity - Activation of liver X receptor suppresses the production of the IL-12 family of cytokines by blocking nuclear translocation of NF-kappa Bp50 - Validated - Altmetric: 1 () - Liver X receptor dendritic cells interleukin-12 NF-kappa B NF-KAPPA-B INFLAMMATORY-BOWEL-DISEASE DENDRITIC CELLS PPAR-GAMMA C-REL INDUCTION TRANSCRIPTION MACROPHAGES EXPRESSION HOMEOSTASIS - 20 - 675 - 687 - There is now convincing evidence that liver X receptor (LXR) is an important modulator of the inflammatory response; however, its mechanism of action remains unclear. This study aimed to examine the effect of LXR on the IL-12 family of cytokines and examined the mechanism by which LXR exerted this effect. We first demonstrated that activation of murine-derived dendritic cells (DC) with a specific agonist to LXR enhanced expression of LXR following activation with LPS, suggesting a role in inflammation. Furthermore, we showed LXR expression to be increased in vivo in dextrane sulphate sodium-induced colitis. LXR activation also suppressed production of IL-12p40, IL-12p70, IL-27 and IL-23 in murine-derived DC following stimulation with LPS, and specifically targeted the p35, p40 and EBI3 subunits of the IL-12 cytokine family, which are under the control of the NF-kappa B subunit p50 (NF-kappa Bp50). Finally, we demonstrated that LXR can associate with NF-kappa Bp50 in DC and that LXR activation prevents translocation of the p50 subunit into the nucleus. In summary, our study indicates that LXR can specifically suppress the IL-12 family of cytokines though its association with NF-kappa Bp50 and highlights its potential as a therapeutic target for chronic inflammatory diseases. - 10.1177/1753425913501915 DA - 2014/10 ER -
BIBTeX format for JabRef and similar
@article{V279268961, = {Canavan, M and McCarthy, C and Ben Larbi, N and Dowling, JK and Collins, L and O'Sullivan, F and Hurley, G and Murphy, C and Quinlan, A and Moloney, G and Darby, T and MacSharry, J and Kagechika, H and Moynagh, P and Melgar, S and Loscher, CE }, = {2014}, = {October}, = {Innate Immunity}, = {Activation of liver X receptor suppresses the production of the IL-12 family of cytokines by blocking nuclear translocation of NF-kappa Bp50}, = {Validated}, = {Altmetric: 1 ()}, = {Liver X receptor dendritic cells interleukin-12 NF-kappa B NF-KAPPA-B INFLAMMATORY-BOWEL-DISEASE DENDRITIC CELLS PPAR-GAMMA C-REL INDUCTION TRANSCRIPTION MACROPHAGES EXPRESSION HOMEOSTASIS}, = {20}, pages = {675--687}, = {{There is now convincing evidence that liver X receptor (LXR) is an important modulator of the inflammatory response; however, its mechanism of action remains unclear. This study aimed to examine the effect of LXR on the IL-12 family of cytokines and examined the mechanism by which LXR exerted this effect. We first demonstrated that activation of murine-derived dendritic cells (DC) with a specific agonist to LXR enhanced expression of LXR following activation with LPS, suggesting a role in inflammation. Furthermore, we showed LXR expression to be increased in vivo in dextrane sulphate sodium-induced colitis. LXR activation also suppressed production of IL-12p40, IL-12p70, IL-27 and IL-23 in murine-derived DC following stimulation with LPS, and specifically targeted the p35, p40 and EBI3 subunits of the IL-12 cytokine family, which are under the control of the NF-kappa B subunit p50 (NF-kappa Bp50). Finally, we demonstrated that LXR can associate with NF-kappa Bp50 in DC and that LXR activation prevents translocation of the p50 subunit into the nucleus. In summary, our study indicates that LXR can specifically suppress the IL-12 family of cytokines though its association with NF-kappa Bp50 and highlights its potential as a therapeutic target for chronic inflammatory diseases.}}, = {10.1177/1753425913501915}, source = {IRIS} }
Data as stored in IRIS
AUTHORS | Canavan, M,McCarthy, C,Ben Larbi, N,Dowling, JK,Collins, L,O'Sullivan, F,Hurley, G,Murphy, C,Quinlan, A,Moloney, G,Darby, T,MacSharry, J,Kagechika, H,Moynagh, P,Melgar, S,Loscher, CE | ||
YEAR | 2014 | ||
MONTH | October | ||
JOURNAL_CODE | Innate Immunity | ||
TITLE | Activation of liver X receptor suppresses the production of the IL-12 family of cytokines by blocking nuclear translocation of NF-kappa Bp50 | ||
STATUS | Validated | ||
TIMES_CITED | Altmetric: 1 () | ||
SEARCH_KEYWORD | Liver X receptor dendritic cells interleukin-12 NF-kappa B NF-KAPPA-B INFLAMMATORY-BOWEL-DISEASE DENDRITIC CELLS PPAR-GAMMA C-REL INDUCTION TRANSCRIPTION MACROPHAGES EXPRESSION HOMEOSTASIS | ||
VOLUME | 20 | ||
ISSUE | |||
START_PAGE | 675 | ||
END_PAGE | 687 | ||
ABSTRACT | There is now convincing evidence that liver X receptor (LXR) is an important modulator of the inflammatory response; however, its mechanism of action remains unclear. This study aimed to examine the effect of LXR on the IL-12 family of cytokines and examined the mechanism by which LXR exerted this effect. We first demonstrated that activation of murine-derived dendritic cells (DC) with a specific agonist to LXR enhanced expression of LXR following activation with LPS, suggesting a role in inflammation. Furthermore, we showed LXR expression to be increased in vivo in dextrane sulphate sodium-induced colitis. LXR activation also suppressed production of IL-12p40, IL-12p70, IL-27 and IL-23 in murine-derived DC following stimulation with LPS, and specifically targeted the p35, p40 and EBI3 subunits of the IL-12 cytokine family, which are under the control of the NF-kappa B subunit p50 (NF-kappa Bp50). Finally, we demonstrated that LXR can associate with NF-kappa Bp50 in DC and that LXR activation prevents translocation of the p50 subunit into the nucleus. In summary, our study indicates that LXR can specifically suppress the IL-12 family of cytokines though its association with NF-kappa Bp50 and highlights its potential as a therapeutic target for chronic inflammatory diseases. | ||
PUBLISHER_LOCATION | |||
ISBN_ISSN | |||
EDITION | |||
URL | |||
DOI_LINK | 10.1177/1753425913501915 | ||
FUNDING_BODY | |||
GRANT_DETAILS |